Compare MobilEye Global Inc (MBLY) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MobilEye Global Inc vs Moderna, Inc. — how do they compare? MobilEye Global Inc trades at $8.98 (market cap $7.54B), while Moderna, Inc. trades at $59.73 (market cap $23.60B). The key difference: Moderna, Inc. is far larger — about 3.1× MobilEye Global Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, MobilEye Global Inc nearer its low. Which is the better fit depends on your goals.
| MBLY | MRNA | |
|---|---|---|
Market Cap | $7.54B | $23.60B |
Sector | Technology | Health |
52-Week High | $16.19 | $81.80 |
52-Week Low | $6.56 | $22.36 |
Enterprise Value | $6.19B | $19.70B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MobilEye Global Inc
Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
